Benefits and adverse effects of endocrine therapy - Wikidata - wikimedia - TriplyDB

Benefits and adverse effects of endocrine therapy

Benefits and adverse effects of endocrine therapy

http://www.wikidata.org/entity/Q35135718

about

The Modern Landscape of Endocrine Therapy for Premenopausal Women with Breast Cancer Androgen receptor genotypes predict response to endocrine treatment in breast cancer patients.S4646 polymorphism in CYP19A1 gene is associated with the efficacy of hormone therapy in early breast cancer.High-intensity focused ultrasound compared with irradiation for ovarian castration in premenopausal females with hormone receptor-positive breast cancer after radical mastectomy Anastrozole-associated joint pain and other symptoms in patients with breast cancer.Hormonal therapies in young breast cancer patients: when, what and for how long?The importance of nonpharmacogenetic factors in endocrine therapy.New insights into endocrine therapy for young women with breast cancer.Navigating the Challenges of Endocrine Treatments in Premenopausal Women with ER-Positive Early Breast Cancer.The inhibitory effects of the standardized extracts of Ginkgo biloba on Aromatase activity in JEG-3 human choriocarcinoma cells.

P2860

Q28085160-0EDCB1FE-6FC8-4020-B13C-A40EDEA9591C Q34228066-95B1BA4E-7E2D-4484-A4CF-5FA4B07E8110 Q35854143-C5D84004-A1EB-4DA1-85D2-627A510A7DEA Q36403405-2CB626DB-8211-4277-B7CA-B65A85AC27D2 Q36655900-EB8FD0E2-4D25-43C0-9A33-B931F0262D72 Q36963393-AA7461F2-8C4F-4313-B291-0035A9F76A9F Q38003706-A155C3AC-6736-4974-8073-5E7812F3BBC7 Q38535371-C4EBAD45-72A9-4200-84B0-2D729ACF67D4 Q38547729-0E563B74-DEB4-4687-931B-D7A18D951B7A Q39206891-4F7323A6-C433-40BC-B812-5F97B757284C

P2860

Benefits and adverse effects of endocrine therapy

http://www.wikidata.org/entity/Q35135718

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Benefits and adverse effects of endocrine therapy

@ast

Benefits and adverse effects of endocrine therapy

@en

type

label

Benefits and adverse effects of endocrine therapy

@ast

Benefits and adverse effects of endocrine therapy

@en

prefLabel

Benefits and adverse effects of endocrine therapy

@ast

Benefits and adverse effects of endocrine therapy

@en

P1433

Q35135718-90C6D2AD-2E79-47AE-8E9C-16FA2B88090E

P1476

Q35135718-CF028793-6BF7-488F-8B6A-7A85CC3B089D

P2093

Q35135718-9A569A56-82AE-485B-9CE9-78DC1EEE5E65

P2860

Q35135718-0B76EE49-5834-4602-B97C-F22F4789C367

Q35135718-11521E84-87F0-4A8F-BBDD-897852B45348

Q35135718-131CC2C8-BCEE-4CAC-BC63-DCFED31D9043

Q35135718-27634071-9417-409E-AA31-22FEAF2901F4

Q35135718-27C988AE-B93B-4345-A2B9-17615F108400

Q35135718-4682C1FB-8A38-43B2-90BA-C12973C8F140

Q35135718-52ED27F6-F0F0-4BC5-85E8-8D397B4B1251

Q35135718-62E40F66-4509-40A8-836B-6677B908351A

Q35135718-682F599F-8910-4913-A5D5-64ABA7B4EB35

Q35135718-71E5C211-380E-45C8-A90A-7F43A8D5725C

P304

Q35135718-2EE9732F-2CBB-4DD7-8C3D-6AB5DC502234

P31

Q35135718-FE5E0923-9F3F-46BF-A6F8-7F65A8919265

P356

Q35135718-6648D890-3391-4FC2-9EE7-6A5FA1337390

P478

Q35135718-E1A7A5A7-7622-49E6-BD37-E2445061A708

P50

Q35135718-76E513EB-989D-4B45-A2EB-1022F9517042

P577

Q35135718-76EB140D-F7B4-4924-894C-7D5B5463AA4F

P5875

Q35135718-A1971F45-76A4-4571-A5D8-AC7211678C97

P698

Q35135718-7C9450F7-11F1-46F5-A4E3-BE95B25E7BDA

P932

Q35135718-64F4BE42-E7BB-4206-9EE9-FA3B5C270689

P356

P1433

Annals of Oncology

P1476

Benefits and adverse effects of endocrine therapy

@en

P2093

A Giobbie-Hurder

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009

Has tamoxifen had its day?

The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen.

Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials.

Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?

Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

P304

vii107-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ANNONC/MDQ281

http://www.w3.org/2001/XMLSchema#string

P478

21 Suppl 7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47414522

http://www.w3.org/2001/XMLSchema#string

P698

20943602

http://www.w3.org/2001/XMLSchema#string

P932

3146255

http://www.w3.org/2001/XMLSchema#string